---
title: "Cara Therapeutics initiates 1-for-3 reverse stock split amid merger with Tvardi Therapeutics, effective per Board approval."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235908896.md"
description: "In Stamford, Connecticut on April 14, 2025, Cara Therapeutics, Inc. disclosed a major decision. The company, listed as CARA on Nasdaq, revealed that its Board of Directors has greenlit a 1-for-3 reverse stock split for its current common stock shares."
datetime: "2025-04-14T16:07:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235908896.md)
  - [en](https://longbridge.com/en/news/235908896.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235908896.md)
---

# Cara Therapeutics initiates 1-for-3 reverse stock split amid merger with Tvardi Therapeutics, effective per Board approval.

In Stamford, Connecticut on April 14, 2025, Cara Therapeutics, Inc. disclosed a major decision. The company, listed as CARA on Nasdaq, revealed that its Board of Directors has greenlit a 1-for-3 reverse stock split for its current common stock shares.

### Related Stocks

- [CARA.US](https://longbridge.com/en/quote/CARA.US.md)

## Related News & Research

- [Why Ero Copper (TSX:ERO) Is Up 10.5% After Record 2025 Output and 2026 Growth Outlook](https://longbridge.com/en/news/282412649.md)